ZyVersa Therapeutics, Inc. Warrants
ZVSAW
ZVSAW was delisted on the 20th of December, 2022.
16 hedge funds and large institutions have $1.84M invested in ZyVersa Therapeutics, Inc. Warrants in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
3% more capital inflows, than outflows
Capital inflows: $232K | Capital outflows: $226K
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$95K |
| 2 |
Periscope Capital
Toronto,
Ontario, Canada
|
+$35.5K |
| 3 |
D.E. Shaw & Co
New York
|
+$30.4K |
| 4 |
Clear Street
New York
|
+$25.5K |
| 5 |
Ancora Advisors
Cleveland,
Ohio
|
+$261 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Cohanzick Management
Pleasantville,
New York
|
-$90K |
| 2 |
RA
RiverPark Advisors
New York
|
-$90K |
| 3 |
Wolverine Asset Management
Chicago,
Illinois
|
-$721 |
ZVSAW Hedge Fund Activity: Q2 2022 in Review
16 of the 5,962 institutional investors tracked by Wall St. Rank reported a position in ZyVersa Therapeutics, Inc. Warrants (ZVSAW) for Q2 2022, worth a combined $1.84M — down 11% from $2.07M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ZVSAW positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was EHP Funds Inc, opening a new position worth an estimated $95K. The largest seller was Cohanzick Management, exiting entirely with an estimated $90K sold.
- 16 institutional investors held ZyVersa Therapeutics, Inc. Warrants (ZVSAW) as of Q2 2022, up from 14 in Q1 2022.
- Funds reported $1.84M of ZyVersa Therapeutics, Inc. Warrants stock for Q2 2022, down 11% quarter-over-quarter.
- 5 funds opened new ZyVersa Therapeutics, Inc. Warrants positions in Q2 2022 and 3 closed out, a net change of +2 holders.
- The largest ZyVersa Therapeutics, Inc. Warrants buyer in Q2 2022 was EHP Funds Inc, an estimated $95K added.
- The largest ZyVersa Therapeutics, Inc. Warrants seller in Q2 2022 was Cohanzick Management, an estimated $90K sold.
Based on aggregated 13F filings for Q2 2022.